Antiviral compositions and method for their use
US5210096A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Jul 10, 1991 |
| Grant date | May 11, 1993 |
| Priority date | — |
| Expiry date | Jul 10, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/555
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions having significant activity as antiviral agent are disclosed containing, as an active component, a compound having the structural formula: ##STR1## wherein R.sub.1 and R.sub.1' are the same or different and each is an alkyl group, a phenyl group or a substituted derivative of a phenyl group; PA0 wherein R.sub.2 and R.sub.2' are the same or different and each is hydrogen, an unbranched alkyl group, a halide or a group having the structure ##STR2## wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; wherein R.sub.3 and R.sub.3' are the same or different and each is hydrogen or an alkyl group; PA0 wherein X and X' are the same or different and each is a water soluble group having weak to intermediate ligand field strength; and PA0 Q.sup.- is a soluble, pharmaceutically acceptable negative ion. Methods of use of the inventive compositions are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.